semaglutide news october 2025 FDA approves Wegovy pill Study finds women much more
Description
prescribing for overweight or obesity was largely off-label, as this indication was not authorized until December 2022
World Journal of Cardiology
shows that the blockbuster class of GLP-1-based medicines are emerging as powerful anti-inflammatory agents and that may help explain why theyre impacting so many conditions beyond obesity and diabetes
Contrave may show initial weight loss within 2-4 weeks, with peak effects usually achieved by week 12-16
What this means for you If you genuinely cannot tolerate injections, sublingual drops represent a theoretical alternative worth discussing with a physician
